Analysis on the correlation factors for hemorrhagic transformation after intravenous thrombolytic therapy

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 6, 2015, Pages 1001-1008

  Zhang, P L ^a   Wang, Y X ^a   Chen, Y ^a   Zhang, C H ^a   Li, C H ^a   Dong, Z ^a   Zhang, S S ^a   Tong, Y F ^a   Li, Y Q ^a   Tong, X G ^a   Wang, J H ^a  

^a TIANJIN HUANHU HOSPITAL   (China)

Author keywords

Acute cerebral infarction; Intravenous thrombolysis; RtPA; Thrombolytic therapy.

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGED; BLEEDING DISORDER; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; COLLATERAL CIRCULATION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FIBRINOLYTIC THERAPY; HEMORRHAGIC TRANSFORMATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PROGNOSIS; REVIEW; ADVERSE EFFECTS; CEREBRAL HEMORRHAGE; CHEMICALLY INDUCED; FOLLOW UP; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; RETROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CEREBRAL HEMORRHAGE; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY;

EID: 84942092094     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. AMENTA PS, YADLA S, CAMPBELL PG, MALTENFORT MG, DEY S, GHOSH S, ALI MS, JALLO JI, TJOUMAKARIS SI, GONZALEZ LF, DUMONT AS, ROSENWASSER RH, JABBOUR PM. Analysis of nonmodifiable risk factors for intracranial aneurysm rupture in a large retrospective cohort. Neurosurgery 2012; 70: 693-701.
2. SONOBE M, YAMAZAKI T, YONEKURA M, KIKUCHI H. Small unruptured intracranial aneurysm verification study: SUAVe study, Japan. Stroke 2010; 41: 1969-1977.
3. DAVIS GG, SWALWELL CI. The incidence of acute cocaine or methamphetamine intoxication in deaths due to ruptured cerebral (berry) aneurysms. J Forensic Sci 1996; 41: 626-628.
4. TSUTSUMI K, UEKI K, MORITA A, KIRINO T. Risk of rupture from incidental cerebral aneurysms. J Neurosurg 2000; 93: 550-553.
5. NAHED BV, DILUNA ML, MORGAN T, OCAL E, HAWKINS AA, OZDUMAN K, KAHLE KT, CHAMBERLAIN A, AMAR AP, GUNEL M. Hypertension, age, and location predict rupture of small intracranial aneurysms. Neurosurgery 2005; 57: 676-683.
6. MCNUHY ML, LEE VH. Management of unruptured intraeranial aneurysms and arteriovenous malformations. Am J Ther 2011; 18: 64-69.
7. Ujiie H, Shinohara C, Kato K. Intraaneurysmal flow and aspect ratio (dome/neck). J Biorheol 2009; 23: 41-48.
8. BURNS JD, HUSTON J 3RD, LAYTON KF, PIEPGRAS DG, BROWN RD JR. Intracranial aneurysm enlargement on serial magnetic resonance angiography: frequency and risk factors. Stroke 2009; 40: 406-411.
9. KOSHY L, EASWER HV, PREMKUMAR S, ALAPATT JP, PILLAI AM, NAIR S, BHATTACHARYA RN, BANERJEE M. Risk factors for aneurismal subarachnoid hemorrhage in an Indian population. Cerebrovasc Dis 2010; 29: 368-374.
10. Unruptured intracranial aneurysms-risk of rupture and risks of surgical intervention. International Study of Unruptured Intracranial Aneurysms Investigators. N Engl J Med 1998; 339: 1725-1733.
11. WEIR B, DISNEY L, KARRISON T. Sizes of ruptured and unruptured aneurysms in relation to their sites and the ages of patients. J Neurosurg 2002; 96: 64-70.
12. DE KEYSER J, GDOVINOVÁ Z, UYTTENBOOGAART M, VROOMEN PC, LUIJCKX GJ. Intravenous alteplase forstroke: Beyond the guidelines and in particular clinical situations. Stroke 2007; 38: 2612-2618.
13. KUBOTA M, YAMAURA A, ONO J. Prevalence of risk factors for aneurismal subarachnoid haemorrhage: results of a Japanese multicentre case control study for stroke. Br J Neurosurg 2001; 15: 474-478.
14. RUIZ-SANDOVAL JL, CANTÚ C, CHIQUETE E, LEÓN-JIMÉNEZ C, ARAUZ A, MURILLO-BONILLA LM, VILLARREAL-CAREAGA J, BARINAGARREMENTERÍA F; RENAMEVASC INVESTIGATORS. Aneurysmal subarachnoid hemorrhage in a Mexican multicenter registry of cerebrovascular disease: the RENAMEVASE study. J Stroke Cerebrovasc Dis 2009; 18: 48-55.
15. DESAI JA, JIN AY, MELANSON M. IV thrombolysis in stroke from a cavernous carotid aneurysm to artery embolus. Can J Neurol Sci 2011; 38: 352-353.
16. JUVELA S. Natural history of unruptured intracranial aneurysms: risks for aneurysm formation, growth, and rupture. Acta Neurochir Suppl 2002; 82: 27-30.
17. KIM JT1, PARK MS, YOON W, CHO KH. Detection and significance of incidental unruptured cerebral aneurysms in patients undergoing intravenous thrombolysis for acute ischemic stroke. J Neuroimaging 2012; 22: 197-200.
18. SALARY M, QUIGLEY MR, WILBERGER JE JR. Relation among aneurysm size, amount of subarachnoid blood, and clinical outcome. J Neurosurg 2007; 107: 13-17.
19. BLACK SP, GERMAN WJ. Observation on the relationship between the volume and the size of the orifice of experimental aneurysms. J Neurosurg 1960; 17: 984-990.
20. SADATOMO T, YUKI K, MIGITA K, TANIGUCHI E, KODAMA Y, KURISU K. Morphological differences between ruptured and unruptured cases in middle cerebral artery aneurysms. Neurosurgery 2008; 62: 602-609.
21. JUVELA S, POUSSA K, PORRAS M. Factors affecting formation and growth of intracranial aneurysms: a long-term follow-up study. Stroke 2001; 32: 485-491.
22. [NO AUTHORS LISTED]. The International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms-risk of rupture and risks of surgical intervention. N Engl J Med 1998; 339: 1725-1733.
23. WBITE PM, WARDLAW JM. Unruptured intracranial aneurysms. J Neurosurg 2003; 30: 336-350.
24. INAGAWA T, HADA H, KATOH Y. Unruptured intracranial aneurysms in elderly patients. Surg Neurol 1992; 38: 364-370.
25. HASHI K. Is it appropriate to exclude patients with unruptured intracranial aneurysms from the indication for intravenous thrombolysis with rt-PA for acute cerebral infarction? Jpn J Stroke 2008:30: 72-76.
26. PRESTIGIACOMO CJ, HE W, CATRAMBONE J, CHUNG S, KASPER L, PASUPULETI L, MITTAL N. Predicting aneurysm rupture probabilities through the application of a computed tomography angiographyderived binary logistic regression model. J Neurosurg 2009; 110: 1-6.
27. EDWARDS NJ, KAMEL H, JOSEPHSON SA. The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms: a case series and review of the literature. Stroke 2012; 43: 412-416.
28. MATSUZAKI T, YOSHINO A, SAKATANI K, KATAYAMA Y. Recanalization of middle cerebral artery and intracranial aneurysm in the same ischemic territory with intravenous administration of recombinant tissue plasminogen activator: case report. J Stroke Cerebrovasc Dis 2011; 20: 269-272.
29. LAI HP, CHENG KM, YU SC, AU YEUNG KM, CHEUNG YL, CHAN CM, POON WS, LUI WM. Size, location, and multiplicity of ruptured intracranial aneurysms in the Hong Kong Chinese population with subarachnoid haemorrhage. Hong Kong Med J 2009; 15: 262-266.
30. YONEDA Y, YAMAMOTO S, HARA Y, YAMASHITA H. Unruptured cerebral aneurysm detected after intravenous tissue plasminogen activator for stroke. Case Rep Neurol 2009; 1: 20-23.
31. HASSAN T, TIMOFEEV EV, SAITO T, SHIMIZU H, EZURA M, MATSUMOTO Y, TAKAYAMA K, TOMINAGA T, TAKAHASHI A. A proposed parent vessel geometry-based categorization of saccular intracranial aneurysms: computational flow dynamics analysis of the risk factors for lesion rupture. J Neurosurg 2005; 103: 662-680.
32. JOU LD, WONG G, DISPENSA B, LAWTON MT, HIGASHI-DA RT, YOUNG WL, SALONER D. Correlation between lumenal geometry changes and hemodynamics in fusiform intracranial aneurysms. AJNR Am J Neuroradiol 2005; 26: 2357-2363.
33. NADER-SEPAHI A, CASIMIRO M, SEN J, KITCHEN ND. Is aspect ratio a reliable predictor of intracranial aneurysm rupture? Neurosurgery 2004; 54: 1343-1347.
34. KANE I, SANDERCOCK P, THOMAS B. Can patients with unruptured intracranial aneurysms be treated with thrombolysis? Cerebrovascular Dis 2005; 20: 51-52.
35. WHITE PM, WARDLAW JM. Unruptured intracranial aneurysms. J Neuroradiol 2003; 30: 336-350.
36. D'OLHABERRIAGUE L, JOSHI N, CHATURVEDI S, MITSIAS P, COPLIN W, LEWANDOWSKI CA, PATEL SC, LEVINE SR. Tissue plasminogen activator for acute ischaemic stroke in patients with unruptured cerebral aneurysms. J Stroke Cerebrovasc Dis 2000; 9: 181-184.
37. HACKE W, KASTE M, FIESCHI C, TONI D, LESAFFRE E, VON KUMMER R, BOYSEN G, BLUHMKI E, HÖXTER G, MA-HAGNE MH, ET AL. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-1025.
38. RAGHAVAN ML, MA B, HARBAUGH RE. Quantified aneurysm shape and rupture risk. J Neurosurg 2005; 102: 355-362.
39. [NO AUTHORS LISTED]. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
40. HOH BL, SISTROM CL, FIRMENT CS, FAUTHEREE GL, VE-LAT GJ, WHITING JH, REAVEY-CANTWELL JF, LEWIS SB. Bottleneck factor and height-width ratio: associa-tion with ruptured aneurysms in patients with multiple cerebral aneurysms. Neurosurg 2007; 61: 716-723.
41. UJIIE H, TAMANO Y, SASAKI K, HORI T. Is the aspect ratio a reliable index for predicting the rupture of a saccular aneurysm. Neurosurg 2001; 48: 495-502.
42. MENG H, WANG Z, HOI Y, GAO L, METAXA E, SWARTZ DD, KOLEGA J. Complex hemodynamics at the apex of an arterial bifurcation induces vascular remodeling resembling cerebral aneurysm initiation. Stroke 2007; 38: 1924-1931.
43. CEBRAL JR, CASTRO MA, APPANABOYINA S, PUTMAN CM, MILLAN D, FRANGI AF. Efficient pipeline for image-based patient-specific analysis of cerebral aneurysm hemodynamics: technique and sensitivity. IEEE Trans Med Imaging 2005; 24: 457-467.
44. MITTAL MK, SEET RC, ZHANG Y, BROWN RD JR, RABIN-STEIN AA. Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms. J Stroke Cerebrovasc Dis 2013; 22: 639-643.
45. YAMAGUCHI T, MORI E, MINEMATSU K, NAKAGAWARA J, HASHI K, SAITO I, SHINOHARA Y; JAPAN ALTEPLASE CLINI-CAL TRIAL (J-ACT) GROUP. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 2006; 37: 1810-1815.
46. ALEU A, MELLADO P, LICHY C, KÖHRMANN M, SCHELLINGER PD. Hemorrhagic complications after off-label thrombolysis for ischemic stroke. Stroke 2007; 38: 417-422.
47. VLAK MH, RINKEL GJ, GREEBE P, VAN DER BOM JG, AL-GRA A. Trigger factors for rupture of intracranial aneurysms in relation to patient and aneurysm characteristics. J Neurol 2012; 259: 1298-1302.
48. OHASHI Y, HORIKOSHI T, SUGITA M, YAGISHITA T, NUKUI H. Size of cerebral aneurysms and related factors in patients with subarachnoid hemorrhage. Surg Neurol 2004; 61: 239-245.
49. HACKE W, KASTE M, FIESCHI C, VON KUMMER R, DAVAL-OS A, MEIER D, LARRUE V, BLUHMKI E, DAVIS S, DON-NAN G, SCHNEIDER D, DIEZ-TEJEDOR E, TROUILLAS P. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemicstroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998; 352: 1245-1251.
50. WermerM.J. Van DerSCHAAF Ic AlgraA. RinkelG.J.Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics: An updated meta-analysisStroke2007381404-1410